相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The anti-cancer potential of 2,4,6 tris-methyphenylamino1,3,5-triazine compound against mammary glands cancer: Via down-regulating the hormonal, inflammatory mediators, and oxidative stress
Yumna Mehmood et al.
LIFE SCIENCES (2021)
Pharmacophore modeling, 3D-QSAR, synthesis, and anti-lung cancer evaluation of novel thieno[2,3-d][1,2,3]triazines targeting EGFR
Ranza Elrayess et al.
ARCHIV DER PHARMAZIE (2020)
Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4-aminoquinoline-1,3,5-triazine derivatives
Hans Raj Bhat et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2020)
Barbiturate- and Thiobarbituarte-Based s-Triazine Hydrazone Derivatives with Promising Antiproliferative Activities
Hessa Al Rasheed et al.
ACS OMEGA (2020)
Synthesis, biological evaluation, andin silicostudies of novel chalcone- and pyrazoline-based 1,3,5-triazines as potential anticancer agents
Leydi M. Moreno et al.
RSC ADVANCES (2020)
Design, synthesis, and biological evaluation of new 6,N2-diaryl-1,3,5-triazine-2,4-diamines as anticancer agents selectively targeting triple negative breast cancer cells
Ahmad Junaid et al.
RSC ADVANCES (2020)
6,N2-Diaryl-1,3,5-triazine-2,4-diamines: synthesis, antiproliferative activity and 3D-QSAR modeling
Ahmad Junaid et al.
RSC ADVANCES (2020)
Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos
Muhammad Farooq et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis, characterization, and antiproliferative and apoptosis inducing effects of novel s-triazine derivatives
Mani Shanmugam et al.
NEW JOURNAL OF CHEMISTRY (2018)
Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity
Prateek Pathak et al.
INFLAMMOPHARMACOLOGY (2018)
Preparation and Antiviral Activity of Some New C3- and Cs-Symmetrical Tri-Substituted Triazine Derivatives Having Benzylamine Substituents
Nobuko Mibu et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2018)
Synthesis of New 1,3,5-Triazine-Based 2-Pyrazolines as Potential Anticancer Agents
Leydi M. Moreno et al.
MOLECULES (2018)
Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives
Tamer Nasr et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase
Jitendra Kumar Srivastava et al.
SCIENTIFIC REPORTS (2017)
Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity
Khadijah M. Al-Zaydi et al.
CHEMISTRY CENTRAL JOURNAL (2017)
Discovery of anti-cancer activity for benzo[1,2,4]triazin-7-ones: Very strong correlation to pleurotin and thioredoxin reductase inhibition
Martin Sweeney et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors
Yin-Bo Fan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
New approaches to the synthesis of sildenafil analogues and their enzyme inhibitory activity
Mariusz Mojzych et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors
Mariusz Mojzych et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis and characterization of new s-triazine bearing benzimidazole and benzothiazole derivatives as anticancer agents
G. Jagadeesh Kumar et al.
MEDICINAL CHEMISTRY RESEARCH (2015)
Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity
Mariusz Mojzych et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
New benzothieno[3,2-d]-1,2,3-triazines with antiproliferative activity: Synthesis, spectroscopic studies, and biological activity
Antonino Lauria et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines
Mariusz Mojzych et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and biological evaluation of substituted 1,2,3-benzotriazines and pyrido[3,2-d]-1,2,3-triazines as inhibitors of vascular endothelial growth factor receptor-2
Xing-Wang Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Synthesis and anticancer activity of some new s-triazine derivatives
G. Jagadeesh Kumar et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids
Sunny Manohar et al.
RSC Advances (2013)
Synthesis and Analgesic-Anti-inflammatory Activities of Some 1, 2, 4-Triazine Derivatives
Abdelmoneim Makhlouf et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
Synthesis and antihistaminic activity of 3H-benzo [4,5] thieno [2,3-d][1,2,3] triazin-4-ones
Gollapalle L. Viswanatha et al.
SAUDI PHARMACEUTICAL JOURNAL (2012)
Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial, antimycobacterial and anticancer agents
Rahul V. Patel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
5-Arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonists
William D. Schmitz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and cytotoxicity evaluation of (tetrahydro-β-carboline)-1,3,5-triazine hybrids as anticancer agents
Ravi Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor
Aranapakam M. Venkatesan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Selective synthesis and biological activity of triazine-porphyrins as potential anti-cancer agents
Shen-Chu Xiao et al.
JOURNAL OF PORPHYRINS AND PHTHALOCYANINES (2010)
Cyclocondensation reaction of heterocyclic carbonyl compounds, Part XIII: Synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines
Tomas Gucky et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Design, synthesis, and antitumor activities of some novel substituted 1,2,3-benzotriazines
Jin-Ling Lv et al.
MOLECULES (2008)
Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives
Mingfang Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors
GH Kuo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(β-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(β-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-β-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexa-azaacenaphthylene as analogues of triciribine
MT Migawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
2-Hydroxy-4,6-diamino-[1,3,5]triazines: A novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors
N Baindur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase
K Leftheris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening
HS Moon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)